Eden Research (LON:EDEN – Get Free Report) issued its quarterly earnings data on Wednesday. The company reported GBX (0.36) EPS for the quarter, Digital Look Earnings reports. Eden Research had a negative net margin of 44.31% and a negative return on equity of 15.05%.
Eden Research Price Performance
EDEN stock opened at GBX 2.19 on Wednesday. Eden Research has a 1 year low of GBX 1.96 and a 1 year high of GBX 5. The company has a debt-to-equity ratio of 1.43, a quick ratio of 2.42 and a current ratio of 2.25. The stock’s 50 day moving average price is GBX 2.73 and its 200 day moving average price is GBX 3.17. The firm has a market cap of £17.58 million, a P/E ratio of -4.94 and a beta of 1.57.
About Eden Research
Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites. To date, they have been primarily used on high-value fruits and vegetables, improving crop yields and marketability, with equal or better performance when compared with conventional pesticides.
Read More
- Five stocks we like better than Eden Research
- Marzetti Stock Confirms Reversal on Earnings Strength, Dividend Growth
- Pathward’s Credit Scare Tests Its Comeback Story
- Wiring the AI Boom: Rumble’s $13.7B Pivot
- StoneX: Too Far Too Fast?
Receive News & Ratings for Eden Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eden Research and related companies with MarketBeat.com's FREE daily email newsletter.
